Kinnevik Technology Fund

What they fund

• Stage — All stages of a company's growth journey, with a focus on growth-stage companies [1].
• Sector — Healthcare, software, and climate [1].
• Geography — Europe and the US [1].
• Company Shape — Challenger technology-enabled businesses with scalable business models and strong revenue generation capabilities [1].

Credibility: Kinnevik's homepage details its investment focus, including sectors, geography, and company characteristics [1].

Investment thesis

Kinnevik is a leading growth investor, active owner and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US [1]. The firm targets companies with scalable business models and strong revenue generation capabilities, aiming to redefine industries and create remarkable growth companies [1]. It invests at all stages of a company's growth journey, with a focus on healthcare, software, and climate sectors [1]. Kinnevik leverages its own balance sheet to provide patient capital, acting as a strategic partner to passionate founders building tomorrow's leaders [1].

Credibility: Kinnevik's homepage explicitly states its mission, target sectors, and investment approach, confirming its role as an active owner and growth investor [1].

Value add

Kinnevik acts as an active owner and operational partner, providing patient capital and strategic guidance to portfolio companies [1]. It leverages its extensive network and expertise to help founders build tomorrow's leaders [1].

Fit verdict: Kinnevik is a strong fit for growth-stage technology-enabled businesses in healthcare, software, and climate, seeking patient capital and operational support.

Founder diligence script:

• What specific operational support does Kinnevik provide to portfolio companies?
• How does Kinnevik's network benefit portfolio companies in terms of business development and partnerships?
• What is Kinnevik's typical timeline for decision-making and capital deployment?
• How does Kinnevik measure success and define long-term value creation?
• What is Kinnevik's approach to board involvement and governance?

Portfolio focus

• Healthcare — Companies like Spring Health, Cityblock, Oviva, Enveda Biosciences, Tandem Health, and Strand Therapeutics [1].
• Enterprise Software — Companies like Mews and Pleo [1].

Credibility: Kinnevik's homepage lists these companies under its spotlight companies, confirming their portfolio status [1].

Notable investments & exits

Kinnevik has distributed 87.7 SEKbn in value since 2018, indicating successful exits and value creation [1]. Specific exit details are not provided on the homepage, but the firm's track record suggests a history of successful investments [1].

Credibility: Kinnevik's homepage states the total distributed value since 2018, confirming its exit track record [1].

Strategic implications

Kinnevik's strength lies in its patient capital and active ownership model, which allows it to support portfolio companies through long-term growth journeys. A key risk is the firm's reliance on its own balance sheet, which may limit its ability to deploy capital during market downturns. A signal that would change the read is if Kinnevik shifts its focus away from technology-enabled businesses or reduces its active ownership role.

Where they could go further

Kinnevik could expand its geographic focus to include emerging markets, tapping into new growth opportunities. The firm could enhance its operational support by developing specialized programs for portfolio companies in the climate sector. Kinnevik could improve its transparency by providing more detailed updates on its investment activities and portfolio performance.